VANCOUVER, British Columbia, Jan. 27, 2021 (GLOBE NEWSWIRE) â
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV)Â (âJuva Life,â âJuvaâ or the âCompanyâ
), a California based life sciences company focused on the research and development, and commercialization of Cannabis products is pleased to offer an update regarding intellectual property protection matters and concurrent capital markets activities.
Juva Life is a life science company focused on the identification and characterization of evidenced based safe cannabis products. The Company has developed a unique platform that enables the identification of products targeting inflammatory conditions. Juva will protect these inventions through holding as trade secret certain discovery technologies and patenting novel compositions of matter and uses. Directing these activities within the Company is Sanjeev Gangwar, Ph.D., Vice President of Chemistry. Dr. Gangwar brings significant experien
#3 This Is A Big Data Coup
Cannabis data is the difference between a successful market and a
very successful market.
It’s the only thing connecting medical cannabis to medical science …
It’s the missing element that could cut millions of dollars off the costs of getting new cannabis based pharmaceutical drugs approved …
That also means it’s one thing that will attract the lucrative attention of Big Pharma.
It’s also one thing Juva has brought to the table.
And when the company went public in November, it heralded a business plan of creating a potential lucrative nexus between medical cannabis and big pharma.
) aims to have a large database for evidence-based cannabis treatments…
And they’ll soon have the facilities to take that valuable data proving what works best and for who…
And turn it into an asset that could potentially make them an instant acquisition target.
Here are 3 key reasons why you should be watching Juva Life.
A New Path for Safe, Effective Treatments
The start of this massive boom began in California, when they legalized medical marijuana with overwhelming support in 1996.
Since then, dozens of other states and entire nations have jumped onboard…
And the global cannabis industry is expected to reach an incredible $57 billion by 2025.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis .
Juva Life Inc.January 21, 2021 GMT
VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California-based life science company today announces the launch of a clinical registry to evaluate rationally designed cannabis formulations for clinical effect and mode of action. This is the first step towards building an integrated technology platform addressing serious and unmet medical needs.
There is a substantial body of pre-clinical, clinical, and anecdotal data consistent with a cannabis effect, but despite significant investment and opportunity, there is an absence of understanding of “how cannabis works” to pair the right formulation with the right indication. Juva has de
Share this article
Share this article
NEW YORK, Jan. 21, 2021 /PRNewswire/ On October 10, 1962, JFK signed into law a little-known act that helped put a massive $1.25 trillion industry on the map. And today, the trillion-dollar pharmaceutical industry is being pushed to make a shift. Mentioned in today s commentary includes:
AbbVie Inc. (NYSE: ABBV),
NewAge, Inc. (NASDAQ: NBEV),
The Scotts Miracle-Gro Company (NYSE: SMG),
Aphria Inc. (NASDAQ: APHA),
The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF).
This is a new way to create safe, proven treatments while saving companies significant amounts of money.Treatments that could help ease common ailments that plague millions of folks each year like chronic pain, inflammation, migraines, and more.